Detalhe da pesquisa
1.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
N Engl J Med
; 389(23): 2162-2174, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38055253
2.
Current recommendations and recent progress in endometrial cancer.
CA Cancer J Clin
; 69(4): 258-279, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31074865
3.
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer.
Cancer
; 130(8): 1234-1245, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127487
4.
A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283.
Gynecol Oncol
; 176: 16-24, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37418832
5.
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study.
Gynecol Oncol
; 164(3): 481-491, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063278
6.
Immune checkpoint inhibitors in women with gynecologic cancers: Practical considerations.
Gynecol Oncol
; 158(3): 531-537, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32641238
7.
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.
Nat Med
; 13(9): 1096-101, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17721544
8.
Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer.
J Clin Invest
; 132(14)2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35671108
9.
Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer.
JAMA Oncol
; 8(9): 1317-1322, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35900726
10.
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors.
Clin Cancer Res
; 27(20): 5510-5518, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34168049
11.
Phase I clinical trials in 85 patients with gynecologic cancer: the M. D. Anderson Cancer Center experience.
Gynecol Oncol
; 117(3): 467-72, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20347123
12.
Safety and Clinical Activity of Atezolizumab Plus Bevacizumab in Patients with Ovarian Cancer: A Phase Ib Study.
Clin Cancer Res
; 26(21): 5631-5637, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723836
13.
Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial.
Clin Cancer Res
; 26(24): 6437-6444, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33028595
14.
Aflibercept in epithelial ovarian carcinoma.
Future Oncol
; 5(5): 591-600, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19519199
15.
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma.
JAMA Oncol
; 5(8): 1141-1149, 2019 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31194228
16.
Laparoscopy training in gynecologic oncology fellowship programs.
Gynecol Oncol
; 111(2): 197-201, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18804849
17.
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors.
J Clin Oncol
; 36(16): 1611-1618, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29437535
18.
Potential role of radiation therapy in augmenting the activity of immunotherapy for gynecologic cancers.
Cancer Manag Res
; 9: 553-563, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29184441
19.
Ovarian Sertoli-Leydig Cell Tumor with Elevated Inhibin B as a Cause of Secondary Amenorrhea in an Adolescent with Germ Line DICER1 Mutation.
J Pediatr Adolesc Gynecol
; 30(5): 598-600, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28502826
20.
Robotic surgical staging for cervical cancer diagnosed during pregnancy: Immediate versus delayed definitive treatment.
Gynecol Oncol Case Rep
; 5: 40-2, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24371693